Insel Gruppe Ag, University Hospital Bern
Clinical trials sponsored by Insel Gruppe Ag, University Hospital Bern, explained in plain language.
-
Weight-Loss drug may curb alcohol cravings in fatty liver patients
Disease control Not yet recruitingThis study tests whether semaglutide (a GLP-1 drug used for diabetes and weight loss) can help people with obesity and fatty liver disease reduce or stop drinking alcohol. 64 participants will receive either semaglutide injections plus lifestyle counseling, or counseling alone. T…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
Gut check: can probiotics tame IBD in kids?
Disease control Not yet recruitingThis study looks at whether taking a mix of probiotics (good bacteria) can change the gut microbiome of children and teens aged 5-18 with inflammatory bowel disease (IBD). About 40 participants will be randomly assigned to take probiotics or a placebo, then switch after a period.…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New hope for kidney stone sufferers: drug and diet combo tested in major trial
Disease control Not yet recruitingThis study tests two approaches to prevent kidney stones from coming back in people who have had them before. One approach uses a daily pill called empagliflozin (a diabetes drug) and the other gives personalized diet advice based on urine tests. The trial will involve 400 adults…
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
Disease control Not yet recruitingThis study tests whether people with giant cell arteritis (GCA) can safely take steroids for only 8 weeks instead of the usual 26 weeks when also using the drug tocilizumab. About 178 participants will be randomly assigned to one of two treatment lengths. The goal is to see if th…
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Migraine drug may stop altitude sickness before it starts
Prevention Not yet recruitingThis study tests whether a single injection of fremanezumab, a drug used to prevent migraines, can stop acute mountain sickness (AMS) in healthy adults. Thirty volunteers will receive either the drug or a placebo one week before climbing to a high-altitude hut. Researchers will t…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Prevention
Last updated Jun 22, 2026 12:06 UTC
-
Can a smartphone app replace physio after hip surgery?
Symptom relief Not yet recruitingThis trial tests whether a 12-week home rehabilitation program using the Akina app is as effective as standard outpatient physiotherapy for older adults (ages 55-80) recovering from hip surgery. Sixty-six participants will either use the digital program at home or receive routine…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Symptom relief
Last updated Jun 23, 2026 19:33 UTC
-
New drug combo may prevent dangerous blood pressure swings during neck surgery
Symptom relief Not yet recruitingThis study tests whether adding the drug dexmedetomidine during carotid artery surgery helps keep blood pressure more stable. About 44 adults having this surgery will be randomly assigned to receive either standard anesthesia alone or standard anesthesia plus dexmedetomidine. The…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Symptom relief
Last updated Jun 15, 2026 19:09 UTC
-
Cochlear implants may do more than help you hear
Knowledge-focused Not yet recruitingThis study looks at whether turning on a cochlear implant affects a person's sense of direction and balance. Seven hundred adult cochlear implant users will take online surveys and perform balance tests under different implant settings. The goal is to see if the implant's sound c…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:55 UTC
-
Kids, parents, and doctors team up to decide what matters most in Children's anesthesia research
Knowledge-focused Not yet recruitingThis study aims to find out what children, their parents, and doctors think are the most important research topics in pediatric anesthesia and surgery care. About 1,040 participants in Switzerland will share their views through online surveys. The results will help guide future s…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC
-
One night not enough? sleep apnea study tests nightly variability
Knowledge-focused Not yet recruitingThis study looks at how sleep apnea test results vary from night to night. Researchers will track 192 people with suspected or diagnosed sleep apnea over multiple nights at home. The goal is to find which measurements are most stable and reliable for diagnosis, potentially improv…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC
-
Synthetic nicotine under the microscope: are they safer?
Knowledge-focused Not yet recruitingThis study aims to understand how synthetic nicotine and nicotine-like chemicals affect the body compared to regular tobacco nicotine. Researchers will measure nicotine levels in the blood of 24 adult vapers after they use different products. The goal is to learn more about their…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC
-
Blood test may replace needle biopsies for prostate cancer watch
Knowledge-focused Not yet recruitingThis study tests whether the Stockholm3 blood test can accurately detect when low-risk prostate cancer becomes more aggressive in men who are closely monitored instead of treated immediately. Researchers will enroll 350 men on active surveillance to see if the test can reduce the…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC